Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00011323 · ClinicalTrials.gov registry record

Determining the Risk Factors Such as Smoking, Alcohol, and Caffeine and Their Association With Osteoporosis in Men

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
1,000
Enrollment target

NCT00011323: Completed study, sponsored by US Department of Veterans Affairs.

NCT00011323 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00011323 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
1,000 participants
Enrollment target

Study Summary

The goals of this project are to establish a new cohort of male veterans and describe associations between potential risk factors and baseline bone mineral density (BMD) as well as rates of BMD loss.

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 1998-06
Est. Completion 2001-01
US Department of Veterans Affairs

632 total trials

What the finished NCT00011323 record still lists

NCT00011323 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00011323 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00011323 about?

NCT00011323 is a clinical study titled "Determining the Risk Factors Such as Smoking, Alcohol, and Caffeine and Their Association With Osteoporosis in Men". The goals of this project are to establish a new cohort of male veterans and describe associations between potential risk factors and baseline bone mineral density (BMD) as well as rates of BMD loss.

What is the current status of trial NCT00011323?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 1998-06. Estimated completion is 2001-01.

Who is sponsoring clinical trial NCT00011323?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00011323, the US trial registry maintained by the National Library of Medicine. NCT00011323 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.